Stay updated with breaking news from Athersys Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The cell therapy market is poised to grow by USD 21.061 billion from 2021 to 2026, progressing at a CAGR of 56.79% during the forecast period,...
The broader market weakness spread into the biotech sector in the week ending Jan. 28, sending stocks lower. Johnson ...
The Cleveland-based regenerative medicine company that is preparing for commercialization of its MultiStem cell therapy named Daniel A. Camardo as CEO, effective Feb. 14. He also will join the company's board of directors. William (B.J.) Lehmann, who has been interim CEO at Athersys for nearly a year, will return to the roles of president and chief operating officer, which he held prior to the interim appointment.
/PRNewswire/ -- The "Global Soft Tissue Repair Market (2021-2026) by Product, Application, Geography, Competitive Analysis and the Impact of Covid-19 with...
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Alzheimer's disease (AD) is the most common reason of progressive dementia in the elderly population....